Plus Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €103.10M +156.4% €45.27M +1,227.0% 43.9% +0.35 pp N/A N/A
    (estimated) €40.22M +108.7% €3.41M -141.6% 8.5% +0.51 pp N/A N/A
    (estimated) €19.27M +256.3% -€8.21M -30.5% -42.6% +1.8 pp N/A N/A
    (estimated) €5.41M +28.3% -€11.81M -18.7% -218.5% +1.3 pp N/A N/A
    (estimated) €4.21M -15.2% -€14.53M +31.2% -344.7% -1.2 pp N/A N/A
    €4.97M +18.5% -€11.07M -2.5% -222.8% +0.48 pp -€8.88M -18.0% -178.7% +0.80 pp
    €4.19M +2,093.3% -€11.36M -34.3% -271.0% +88 pp -€10.82M +1.8% -258.3% +53 pp
    €191.06K +∞% -€17.29M +51.3% -9,051.3% -91 pp -€10.63M +23.0% -5,563.8% -56 pp
    €0.00 -100.0% -€11.43M +62.6% N/A -€8.65M +27.6% N/A
    €258.44K -95.7% -€7.03M -24.3% -2,719.8% -26 pp -€6.77M +36.0% -2,620.8% -25 pp
    €5.97M +134.6% -€9.29M -13.8% -155.6% +2.7 pp -€4.98M -50.7% -83.4% +3.1 pp
    €2.54M -53.5% -€10.78M -44.3% -423.5% -0.70 pp -€10.10M -28.8% -397.0% -1.4 pp
    €5.47M -43.7% -€19.35M +2.9% -353.9% -1.6 pp -€14.19M -14.6% -259.4% -0.88 pp
    €9.71M -2.4% -€18.80M +17.6% -193.7% -0.33 pp -€16.60M -1.9% -171.1% -0.0085 pp
    €9.94M +53.4% -€15.99M -49.8% -160.8% +3.3 pp -€16.93M -32.3% -170.2% +2.2 pp
    €6.48M -37.7% -€31.87M +42.8% -491.8% -2.8 pp -€25.00M -13.9% -385.8% -1.1 pp
    €10.40M -15.9% -€22.33M -18.9% -214.6% +0.080 pp -€29.04M +9.9% -279.1% -0.65 pp
    €12.37M +45.1% -€27.53M -0.5% -222.6% +1.0 pp -€26.43M -10.9% -213.7% +1.3 pp
    €8.53M -5.9% -€27.68M +18.0% -324.6% -0.66 pp -€29.65M +51.4% -347.8% -1.3 pp
    €9.06M -27.9% -€23.45M +18.4% -258.7% -1.0 pp -€19.59M -2.6% -216.1% -0.56 pp
    €12.56M +114.9% -€19.80M -22.7% -157.6% +2.8 pp -€20.12M -28.5% -160.1% +3.2 pp
    €5.85M +13.3% -€25.62M +4.8% -438.3% +0.36 pp -€28.14M +12.1% -481.5% +0.051 pp
    €5.16M -23.7% -€24.46M +12.7% -474.0% -1.5 pp -€25.10M +120.5% -486.6% -3.2 pp
    €6.76M +32.0% -€21.71M -4.1% -321.0% +1.2 pp -€11.38M -1,891.3% -168.3% -1.8 pp
    €5.12M -11.9% -€22.64M +1,169.8% -441.9% -4.1 pp €635.45K -106.3% 12.4% +1.9 pp
    €5.82M -51.6% -€1.78M -77.5% -30.7% +0.35 pp -€10.05M +114.2% -172.9% -1.3 pp
    €12.02M +53.7% -€7.92M -28.6% -65.9% +0.76 pp -€4.69M -7.9% -39.1% +0.26 pp
    €7.82M +62.3% -€11.09M +16.0% -141.9% +0.57 pp -€5.10M +5.6% -65.2% +0.35 pp
    €4.82M -9.6% -€9.56M +29.6% -198.4% -0.60 pp -€4.83M +2,163.2% -100.2% -0.96 pp
    €5.33M +313.2% -€7.37M +89.1% -138.3% +1.6 pp -€213.24K -95.1% -4.0% +3.3 pp
    €1.29M +∞% -€3.90M +118.7% -302.1% -3.0 pp -€4.36M +235.3% -337.5% -3.4 pp
    €0.00 -€1.78M N/A -€1.30M N/A

    Notifications